Like many others, I switched to DeepSeek during the recent ChatGPT outages and was surprised by its capabilities. If you've ...

Headline-hitting DeepSeek R1, a new chatbot by a Chinese startup, has failed abysmally in key safety and security tests conducted by a research team at Cisco in collaboration with researchers from the ...

DeepSeek-V3.2-Speciale, on the other hand, appears to be competing with the more advanced AI models like Google's Gemini 3.0 ...

Experts find DeepSeek-R1 produces dangerously insecure code when political terms are included in promptsHalf of the politically sensitive prompts trigger DeepSeek-R1 to refuse to generate any codeHard ...

Deepseek version 3.2 packs 671B parameters with 37B active at inference, giving you faster tool use and lower run costs on ...

The Chinese generative artificial intelligence platform DeepSeek has had a meteoric rise this week, stoking rivalries and generating market pressure for United States–based AI companies, which in turn ...

Researchers have tricked DeepSeek, the Chinese generative AI (GenAI) that debuted earlier this month to a whirlwind of publicity and user adoption, into revealing the instructions that define how it ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...

The new artificial intelligence (AI) model from China called DeepSeek created a stock market meltdown on Monday, with the Nasdaq composite dropping 3% and the S&P 500 falling 1.5%. Beyond hammering ...

NEW YORK/LONDON/SINGAPORE >> Investors sold off a host of technology stocks from Tokyo to New York today as they worried that the emergence of a low-cost Chinese artificial intelligence model would ...

AI chatbot DeepSeek has taken the world by storm, topping app store charts and sending Silicon Valley and Wall Street into meltdown. The researchers also noted that DeepSeek can be easily jailbroken, ...

DeepSeek-R1 outperformed OpenAI o1 in diagnostic accuracy (70.4% vs. 63.0%) and management recommendations (82.7% vs. 75.8%) across ophthalmic subspecialties. The study highlighted DeepSeek-R1's ...